Zacks Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Biotech ETF
BBH
|
+$134M |
| 2 |
Amgen
AMGN
|
+$27M |
| 3 |
Williams Companies
WMB
|
+$22.5M |
| 4 |
ExxonMobil
XOM
|
+$14.7M |
| 5 |
AES
AES
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$24.1M |
| 2 |
CME Group
CME
|
+$22.7M |
| 3 |
Crane NXT
CXT
|
+$13.5M |
| 4 |
American Financial Group
AFG
|
+$11.8M |
| 5 |
Verizon
VZ
|
+$8.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.44% |
| 2 | Technology | 13.83% |
| 3 | Industrials | 11.98% |
| 4 | Healthcare | 11.68% |
| 5 | Consumer Staples | 9.91% |
Similar funds
Zacks Investment Management's Q2 2017 Portfolio in Review
As of Q2 2017, Zacks Investment Management held 766 positions worth $4.04B, up 2.7% from $3.93B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Zacks Investment Management deployed $157M of net new capital in Q2 2017, opening 131 new positions and adding to 235 existing holdings. Its largest new stake was VanEck Biotech ETF: 1,114,205 shares worth $1.12M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Exelon, an estimated $24.1M trimmed.
- Zacks Investment Management's largest Q2 2017 buy was VanEck Biotech ETF: 1,114,205 shares worth $1.12M.
- Zacks Investment Management added most to Amgen in Q2 2017, an estimated $27M increase.
- Zacks Investment Management's biggest Q2 2017 reduction was Exelon, cutting an estimated $24.1M.
- Zacks Investment Management fully exited Crane NXT in Q2 2017, selling an estimated $13.5M.
- Zacks Investment Management's ten largest holdings make up 19% of its $4.04B portfolio in Q2 2017.
- Zacks Investment Management opened 131 new positions and closed 186 in Q2 2017.
- Zacks Investment Management's portfolio value rose 2.7% quarter-over-quarter to $4.04B.
Based on Zacks Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.